Research Article
Antibacterial and Antibiotic Modifying Potential of Crude Extracts, Fractions, and Compounds from Acacia polyacantha Willd. against MDR Gram-Negative Bacteria
Table 2
MICs and MBCs in µg/mL of fractions and compounds isolated from the leaf (APL) of Acacia polyacantha and chloramphenicol against a panel of selected Gram-negative bacteria.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(-): > 512 µg/ml for fractions or > 256 µg/ml for compounds; APL: leaf extract; APLa, APLb, and APLd are fractions from APL; 1: stigmasterol, 2: β-amyrin, 3: 3-O-β-glucopyranosylstigmasterol, 4: 3-O-methyl-D-chiro-inositol, 5: epicatechin, 6: quercetin-3-O-glucoside, 7: 3-O-[β-xylopyranosyl-(1→4)-β-galactopyranosyl]-oleanolic acid, 8: 3-O-[β-galactopyranosyl-(1→4)-β-galactopyranosyl]-oleanolic acid; MIC values in bold: significant antibacterial effect [18]. Notes: MICs of fraction APLc > 512 µg/ml and MIC of compounds 1, 2, 3 were > 256 µg/ml in all tested bacteria. |